table of contents table of contents

The recent finding that inhibitors of PI3/Akt can sensitize HIV infected …

Home » Biology Articles » Virology » Hitting HIV where it hides » References

- Hitting HIV where it hides

  1. Sedaghat AR, Siliciano RF, Wilke CO: Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.

    BMC Infect Dis 2008, 8(1):2.


  2. Crowe S, Zhu T, Muller WA: The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection.

    J Leukoc Biol 2003, 74(5):635-641.


  3. Dybul M, Daucher M, Jensen MA, Hallahan CW, Chun TW, Belson M, Hidalgo B, Nickle DC, Yoder C, Metcalf JA, Davey RT, Ehler L, Kress-Rock D, Nies-Kraske E, Liu S, Mullins JI, Fauci AS: Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.

    J Virol 2003, 77(5):3229-3237.


  4. Popovic M, Tenner-Racz K, Pelser C, Stellbrink HJ, van Lunzen J, Lewis G, Kalyanaraman VS, Gallo RC, Racz P: Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

    Proc Natl Acad Sci U S A 2005, 102(41):14807-14812.


  5. Bhoopat L, Rithaporn TS, Khunamornpong S, Bhoopat T, Taylor CR, Thorner PS: Cell reservoirs in lymph nodes infected with HIV-1 subtype E differ from subtype B: identification by combined in situ polymerase chain reaction and immunohistochemistry.

    Mod Pathol 2006, 19(2):255-263.


  6. Siliciano JD, Lai J, Callender M, Pitt E, Zhang H, Margolick JB, Gallant JE, Cofrancesco J Jr., Moore RD, Gange SJ, Siliciano RF: Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.

    J Infect Dis 2007, 195(6):833-836.


  7. Brooks DG, Hamer DH, Arlen PA, Gao L, Bristol G, Kitchen CM, Berger EA, Zack JA: Molecular characterization, reactivation, and depletion of latent HIV.

    Immunity 2003, 19(3):413-423.


  8. Aquaro S, Bagnarelli P, Guenci T, De Luca A, Clementi M, Balestra E, Calio R, Perno CF: Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus.

    J Med Virol 2002, 68(4):479-488.


  9. Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B: Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.

    Proc Natl Acad Sci U S A 1996, 93(2):700-704.


  10. Meltzer MS, Skillman DR, Gomatos PJ, Kalter DC, Gendelman HE: Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection.

    Annu Rev Immunol 1990, 8:169-194.


  11. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection.

    Science 1986, 233(4760):215-219.


  12. Aquaro S, Calio R, Balzarini J, Bellocchi MC, Garaci E, Perno CF: Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.

    Antiviral Res 2002, 55(2):209-225.


  13. Perno CF, Aquaro S, Rosenwirth B, Balestra E, Peichl P, Billich A, Villani N, Calio R: In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages.

    J Leukoc Biol 1994, 56(3):381-386.


  14. Zhang M, Li X, Pang X, Ding L, Wood O, Clouse K, Hewlett I, Dayton AI: Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat.

    J Biomed Sci 2001, 8(3):290-296.


  15. Zhang M, Drenkow J, Lankford CS, Frucht DM, Rabin RL, Gingeras TR, Venkateshan C, Schwartzkopff F, Clouse KA, Dayton AI: HIV regulation of the IL-7R: a viral mechanism for enhancing HIV-1 replication in human macrophages in vitro.

    J Leukoc Biol 2006, 79(6):1328-1338.


  16. Khati M, James W, Gordon S: HIV-macrophage interactions at the cellular and molecular level.

    Arch Immunol Ther Exp (Warsz) 2001, 49(5):367-378.


  17. Singh IN, Goody RJ, Dean C, Ahmad NM, Lutz SE, Knapp PE, Nath A, Hauser KF: Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G.

    J Neurovirol 2004, 10(3):141-151.


  18. Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D: Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia.

    J Neurovirol 1998, 4(3):281-290.


  19. Mattson MP, Haughey NJ, Nath A: Cell death in HIV dementia.

    Cell Death Differ 2005, 12 Suppl 1:893-904.


  20. Kruman, Nath A, Mattson MP: HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress.

    Exp Neurol 1998, 154(2):276-288.


  21. Chugh P, Bradel-Tretheway B, Monteiro-Filh CMR, Planelles V, Maggirwar SB, Dewhurst S, Kim B: Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy.

    Retrovirology 2008, 5(1):11.


  22. Aquaro S, Muscoli C, Ranazzi A, Pollicita M, Granato T, Masuelli L, Modesti A, Perno CF, Mollace V: The contribution of peroxynitrite generation in HIV replication in human primary macrophages.

    Retrovirology 2007, 4:76.


  23. Chugh P, Fan S, Planelles V, Maggirwar SB, Dewhurst S, Kim B: Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line.

    J Mol Biol 2007, 366(1):67-81.


  24. Kan H, Xie Z, Finkel MS: HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappaB activation.

    Am J Physiol Heart Circ Physiol 2000, 279(6):H3138-43.


  25. Polazzi E, Levi G, Minghetti L: Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures.

    J Neuropathol Exp Neurol 1999, 58(8):825-831.


  26. Zhao ML, Kim MO, Morgello S, Lee SC: Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis.

    J Neuroimmunol 2001, 115(1-2):182-191.


  27. Reynolds A, Laurie C, Mosley RL, Gendelman HE: Oxidative stress and the pathogenesis of neurodegenerative disorders.

    Int Rev Neurobiol 2007, 82:297-325.


  28. Goujon C, Riviere L, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix JL, Cimarelli A: SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells.

    Retrovirology 2007, 4:2.


  29. Jacquot G, le Rouzic E, David A, Mazzolini J, Bouchet J, Bouaziz S, Niedergang F, Pancino G, Benichou S: Localization of HIV-1 Vpr to the nuclear envelope: Impact on Vpr functions and virus replication in macrophages.

    Retrovirology 2007, 4(1):84.


  30. Palamara AT, Perno CF, Aquaro S, Bue MC, Dini L, Garaci E: Glutathione inhibits HIV replication by acting at late stages of the virus life cycle.

    AIDS Res Hum Retroviruses 1996, 12(16):1537-1541.


  31. Garaci E, Aquaro S, Lapenta C, Amendola A, Spada M, Covaceuszach S, Perno CF, Belardelli F: Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.

    Proc Natl Acad Sci U S A 2003, 100(15):8927-8932.


rating: 5.00 from 1 votes | updated on: 13 May 2008 | views: 6647 |

Rate article: